Daniel Graver is named as a lobbyist on federal disclosure filings for 3 clients through Akin Gump Strauss Hauer & Feld. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Defense, Pharmacy and Manufacturing.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| ZELIS HEALTHCARE CORPORATION | AKIN GUMP STRAUSS HAUER & FELD | Q3 2026 | Health Issues |
| PRN SOFTWARE, LLC | AKIN GUMP STRAUSS HAUER & FELD | Q3 2026 | Health Issues |
| CENTRIENT PHARMACEUTICALS LLC | AKIN GUMP STRAUSS HAUER & FELD | Q4 2025 | Trade (domestic/foreign), Budget/Appropriations, Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 2 | 1 |
| 2025 | 2 | 1 |
| Year | Items | Total |
|---|---|---|
| 2026 | 2 | $350 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Daniel Graver. See the Capitol Clarity rankings and method.